{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201910291163/fresenius-se-3q-net-profit-sales-grew-backs-outlook", "downloaded_at": "2019-10-29 07:45:17.365106+00:00", "title": "Fresenius SE 3Q Net Profit, Sales Grew; Backs Outlook", "language": "en", "text": "By Carlo Martuscelli\n\nFresenius SE & Co. KGaA (FRE.XE) said Tuesday that net profit and sales both rose in the third quarter, and backed its full-year outlook.\n\nNet income was 444 million euros ($492.4 million), up from EUR419 million in the previous-year period, while sales grew 7.9% to EUR8.42 billion.\n\nThe German provider of health products and services backed its earnings guidance for 2019. The company sees sales growth at constant currency rates of between 4% to 7%, while net income on a comparable basis is expected to be flat.\n\nAt Fresenius Medical Care (FME.XE), the company's dialysis division, net profit rose 17% to EUR333 million, while sales increased by 8.9% to EUR4.42 billion.\n\nWrite to Carlo Martuscelli at carlo.martuscelli@dowjones.com; @carlomartu\n\n(END) Dow Jones Newswires\n\nOctober 29, 2019 02:44 ET (06:44 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-10-29"}